This article reviews the development on drug treatment for visceral leishmaniasis 本文就內(nèi)臟利什曼病藥物治療研究進(jìn)展作扼要綜述。
Most visceral leishmaniasis cases are concentrated in poor populations in just a few countries : india , bangladesh , nepal , sudan and brazil 大多數(shù)內(nèi)臟型利什曼病例都集中在少數(shù)幾個國家的貧民區(qū):印度、孟加拉、尼泊爾、蘇丹和巴西。
Visceral leishmaniasis ( vl ) is prevalent in more than 80 countries in asia , africa ( leishmania donovani ) , southern europe ( l . infantum ) and southern america ( l . chagasi ) 摘要內(nèi)臟利什曼病在亞洲、非洲、南歐、南美洲80多個國家廣泛流行。